BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33405479)

  • 21. Repeated SBRT for in- and out-of-field recurrences in the liver.
    Gkika E; Strouthos I; Kirste S; Adebahr S; Schultheiss M; Bettinger D; Fritsch R; Brass V; Maruschke L; Neeff HP; Lang SA; Nestle U; Grosu AL; Brunner TB
    Strahlenther Onkol; 2019 Mar; 195(3):246-253. PubMed ID: 30353350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-Irradiation of Locoregional NSCLC Recurrence Using Robotic Stereotactic Body Radiotherapy.
    Ceylan C; Hamacı A; Ayata H; Berberoglu K; Kılıç A; Güden M; Engin K
    Oncol Res Treat; 2017; 40(4):207-214. PubMed ID: 28324876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field.
    Horne ZD; Dohopolski MJ; Clump DA; Burton SA; Heron DE
    Pract Radiat Oncol; 2018; 8(3):e117-e123. PubMed ID: 29724402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
    Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
    Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).
    Reyngold M; Wu AJ; McLane A; Zhang Z; Hsu M; Stein NF; Zhou Y; Ho AY; Rosenzweig KE; Yorke ED; Rimner A
    Radiat Oncol; 2013 Apr; 8():99. PubMed ID: 23617949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Méndez Romero A; Schillemans W; van Os R; Koppe F; Haasbeek CJ; Hendriksen EM; Muller K; Ceha HM; Braam PM; Reerink O; Intven MPM; Joye I; Jansen EPM; Westerveld H; Koedijk MS; Heijmen BJM; Buijsen J
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1377-1386. PubMed ID: 33451857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
    Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
    Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study.
    Di Perri D; Jouglar E; Blanc E; Ducassou A; Huchet A; Vigneron C; Escande A; Chapet S; Leseur J; Bernier V; Carrie C; Martin V; Claude L
    Br J Radiol; 2021 Sep; 94(1125):20210176. PubMed ID: 34233469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.
    Owen D; Olivier KR; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
    Radiat Oncol; 2015 Feb; 10():43. PubMed ID: 25889747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.
    Yuce Sari S; Cengiz M; Dauletkazin A; Yazici G; Gultekin M; Hurmuz P; Yildiz F; Zorlu F; Gurkaynak M; Akyol F; Ozyigit G
    Cancer Radiother; 2019 Dec; 23(8):853-859. PubMed ID: 31640927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
    Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
    J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations.
    Bishop AJ; Tao R; Guadagnolo BA; Allen PK; Rebueno NC; Wang XA; Amini B; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
    J Neurosurg Spine; 2017 Sep; 27(3):303-311. PubMed ID: 28644075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.